Mylan's most recent trend suggests a bearish bias. One trading opportunity on Mylan is a Bear Call Spread using a strike $47.00 short call and a strike $52.50 long call offers a potential 7.42% return on risk over the next 18 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $47.00 by expiration. The full premium credit of $0.38 would be kept by the premium seller. The risk of $5.12 would be incurred if the stock rose above the $52.50 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Mylan is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Mylan is bearish.
The RSI indicator is at 35.77 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Mylan
Health care inversions in jeopardy?
Mon, 29 Sep 2014 19:12:00 GMT
Health care inversions in jeopardy?
Mon, 29 Sep 2014 19:12:00 GMT
The Zacks Analyst Blog Highlights: Medtronic, Covidien, Abbott Laboratories, Mylan and Burger King WorldwideThe Zacks Analyst Blog Highlights: Medtronic, Covidien, Abbott Laboratories, Mylan and Burger King Worldwide
Thu, 25 Sep 2014 11:35:17 GMT
Tax crackdown impact on pharma deals
Tue, 23 Sep 2014 18:45:00 GMT
Tax crackdown impact on pharma deals
Tue, 23 Sep 2014 18:45:00 GMT
CNBC – Discussing how the Treasury Department's new rules to end tax inversions could impact the pharma deals, with Michael Faerm, Wells Fargo Securities.
Related Posts
Also on Market Tamer…
Follow Us on Facebook